Discover trends, market shifts, and competitive outlooks for the epigenetics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Epigenetics Market In 2029?

In recent times, the epigenetics market size has witnessed colossal growth. The market is projected to expand from a market value of $10.65 billion in 2024 to a whopping $12.83 billion in 2025, growing at a compound annual growth rate (CAGR) of 20.4%. Factors contributing to this remarkable growth throughout the historic period include increased funding for research, a surge in chronic disease prevalence, the advent of personalized medicine, advancements in cancer research, and the rise in the aging population.

The market of epigenetics is predicted to witness a rapid escalation in the upcoming years, expected to attain a value of $29.08 billion by the year 2029 growing at a Compound Annual Growth Rate (CAGR) of 22.7%. This surge during the forecasted span is due to various factors like the development of epigenetic drugs, application of epigenetics in environmental health and precision agriculture, regulatory backing, heightened patient awareness and advocacy. Key trends during this projection period would be epitranscriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers, research on aging and longevity, and interactions between microbiome-epigenome.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Epigenetics Market?

The epigenetics market is expanding, largely due to the escalating prevalence of diseases such as cancer. This rising disease prevalence stimulates a higher demand for epigenetics. For instance, the National Cancer Institute (NCI), a US government agency, reported that around 20 million new cancer cases were documented in 2022, causing almost 9.7 million deaths. Predictions show that by 2040, the yearly occurrence of new cancer cases will rise to 29.9 million, and the number of deaths related to cancer will reach 15.3 million. Furthermore, the Centers for Disease Control and Prevention (CDC) notes that heart disease annually claims about 659,000 lives in America. Given the growing prevalence of cancer and other diseases, there’s an imperative need to test and understand the genetic modifications involved, leading to augmented usage and demand for epigenetics. Consequently, the escalating prevalence of diseases, particularly cancer, will act as a catalyst propelling the epigenetics market in the future years.

Which Primary Segments of the Epigenetics Market Are Driving Growth and Industry Transformations?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Epigenetics Market?# Market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Most Significant Market Trends in the Epigenetics Market?

Leading corporations within the epigenetics sector are emphasizing the creation of advanced technological solutions such as DNA sequencing methodologies. These efforts aim to augment precision medicine and improve the understanding and outcomes of disease treatment. DNA sequencing methodologies involve procedures that establish the nucleotide sequence of a DNA molecule which facilitates in-depth genetic examinations. Such information is critical for pinpointing disease-related genetic disparities and propelling precision medicine forward. For example, in March 2023, a biotechnology company based in the US, known as Illumina Inc., rolled out the Illumina Complete Long Read Technology. This innovative technology allows for both long-read and short-read sequencing to occur on a single machine, greatly improving versatility within genomic research. This technology simplifies the library preparation process due to its reduced DNA input necessities and streamlined workflow, aiding in its utility for trickier samples. The technology also ensures a high level of accuracy in variant calling and supplies trustworthy data that is vital for wide-ranging genomic examinations.

View the full report here:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

What Parameters Are Used to Define the Epigenetics Market?

Epigenetics is a change in gene activity transmitted to younger cells without modifying the DNA sequence. Epigenetic processes are natural and necessary for many organisms to work, but unusual occurrences can cause disorders, such as various types of cancer, reproductive illnesses, and cardiovascular illnesses. Epigenetics is used detect a type of cancers earlier.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7070

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model